Uncategorized

Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy

Published

5 days ago

on

An ambitious Vancouver startup is trying to ensure the next big diabetes breakthrough retains its ties to Canada, unlike the insulin developers of a century ago.

That startup, Aspect Biosystems, has received $79 million from …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version